Etorera 90mg Tablet contains Etoricoxib, a selective COX-2 inhibitor used primarily for the management of pain and inflammation associated with various musculoskeletal conditions. It is commonly prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis, providing effective relief from joint pain, swelling, and stiffness. Etoricoxib works by selectively blocking the cyclooxygenase-2 enzyme, which plays a key role in the inflammatory process, thereby reducing the production of prostaglandins responsible for pain and inflammation. Compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs), Etoricoxib offers the advantage of a lower risk of gastrointestinal side effects, such as ulcers and bleeding, due to its selective action. The recommended dosage is typically one 90mg tablet once daily, but it should be taken under medical supervision to tailor the dose according to the patient’s condition and response. Patients with cardiovascular disease, kidney or liver impairment should use Etorera cautiously, as it may increase the risk of adverse effects. It is important to follow the prescribed regimen and consult a healthcare provider before starting or discontinuing the medication. Etorera 90mg Tablet is a valuable option for managing chronic inflammatory conditions, improving quality of life by alleviating pain and enhancing mobility.